Breaking News

Thermo Fisher Opens DPM Facility In Singapore

Expands global cell culture and bioprocessing capabilities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thermo Fisher Scientific Inc. is opening a new manufacturing plant in Singapore to produce dry powder media (DPM), an important cell culture raw material used to manufacture biologics, including vaccines and anticancer therapeutics. The facility is the first cell culture DPM production site in Singapore and is designed to meet the increased global requirements from biopharmaceutical companies to mitigate critical raw material supply risks.   The 30,800 sq.-ft. facility will provide manufacturing...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters